Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-047101
Filing Date
2023-08-23
Accepted
2023-08-23 17:46:04
Documents
2
Period of Report
2023-08-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2274
2 POA DOCUMENT poa.txt EX-24 3621
  Complete submission text file 0001209191-23-047101.txt   7350
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Issuer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address AVON PRODUCTS, INC. 1345 AVENUE OF THE AMERICAS NEW YORK NY 10105
Business Address
Harford Simon N.R. (Reporting) CIK: 0001443705 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33497 | Film No.: 231198476